title: Tobramycin once-a-day vs cefoperazone twice-a-day in the therapy of urinary tract infections.
authors.affiliation: Servizio di Patologia Infettiva Urinaria, Istituto di Clinica Medica Generale II, Università di Pisa, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Bonadio
authors.forename: O
authors.initials: O
authors.lastname: Maccanti
authors.forename: S
authors.initials: S
authors.lastname: Cosci
authors.forename: S
authors.initials: S
authors.lastname: Benvenuti
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002438:Cefoperazone / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014031:Tobramycin / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D002438:Cefoperazone; D014031:Tobramycin